J. Huober

543 total citations
21 papers, 331 citations indexed

About

J. Huober is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Huober has authored 21 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Huober's work include Breast Cancer Treatment Studies (8 papers), Advanced Breast Cancer Therapies (6 papers) and Cancer Treatment and Pharmacology (4 papers). J. Huober is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), Advanced Breast Cancer Therapies (6 papers) and Cancer Treatment and Pharmacology (4 papers). J. Huober collaborates with scholars based in Germany, United States and Switzerland. J. Huober's co-authors include Sibylle Loibl, G von Minckwitz, Holger Eidtmann, Claus Hanusch, Sherko Kümmel, B. Gerber, S. D. Costa, K. Mehta, Christian Jackisch and D. Wallwiener and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

J. Huober

18 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Huober Germany	7	218	208	87	42	42	21	331
Lamar Eaton United States	7	114 0.5×	180 0.9×	94 1.1×	49 1.2×	30 0.7×	12	276
Mitsugu Yamamoto Japan	7	252 1.2×	147 0.7×	53 0.6×	68 1.6×	26 0.6×	12	336
Saskia van de Ven Netherlands	8	242 1.1×	193 0.9×	68 0.8×	63 1.5×	64 1.5×	14	361
Lydia Usha United States	9	150 0.7×	82 0.4×	44 0.5×	105 2.5×	18 0.4×	39	296
Bernhard Suchy Germany	10	197 0.9×	112 0.5×	64 0.7×	91 2.2×	21 0.5×	15	322
Р. М. Палтуев Russia	5	270 1.2×	333 1.6×	95 1.1×	17 0.4×	22 0.5×	35	394
Luca Boscolo Bielo Italy	10	132 0.6×	79 0.4×	29 0.3×	58 1.4×	40 1.0×	27	211
Amna Sheri United Kingdom	9	200 0.9×	147 0.7×	66 0.8×	61 1.5×	23 0.5×	20	306
Kailas Munot United Kingdom	4	104 0.5×	87 0.4×	65 0.7×	117 2.8×	51 1.2×	8	272
Audrey Monneur France	10	138 0.6×	97 0.5×	50 0.6×	59 1.4×	10 0.2×	20	251

Countries citing papers authored by J. Huober

Since Specialization

Citations

This map shows the geographic impact of J. Huober's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Huober with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Huober more than expected).

Fields of papers citing papers by J. Huober

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Huober. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Huober. The network helps show where J. Huober may publish in the future.

Co-authorship network of co-authors of J. Huober

This figure shows the co-authorship network connecting the top 25 collaborators of J. Huober. A scholar is included among the top collaborators of J. Huober based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Huober. J. Huober is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Janni, Wolfgang, Thomas W. P. Friedl, Lisa Wiesmüller, et al.. (2025). Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay. ESMO Open. 10(4). 104296–104296. 9 indexed citations

Huober, J., et al.. (2024). Oral Anticancer Therapies: Addressing Nonadherence in Patients With Breast Cancer. Clinical Breast Cancer. 25(4). 307–324.

Huober, J., Roswitha Kammler, Patrizia Dell’Orto, et al.. (2024). 109O Adjuvant endocrine therapy for premenopausal invasive lobular carcinoma (ILC): Results from SOFT and TEXT phase III studies. ESMO Open. 9. 103097–103097. 2 indexed citations

Dirix, Luc, Hans Wildiers, Manon Huizing, et al.. (2020). Abstract OT1-01-05: AIPAC (Active Immunotherapy PAClitaxel): A randomized, double blind, placebo controlled, multinational phase IIb trial evaluating the efficacy of eftilagimod alpha (a soluble LAG-3 fusion protein) in combination with paclitaxel in hormone receptor positive metastatic breast cancer. Cancer Research. 80(4_Supplement). OT1–1. 1 indexed citations

Johnston, Simon J., Mary Beth Martin, Eriko Tokunaga, et al.. (2019). Abstract P6-16-01: Health-related quality of life in MONARCH 3: Abemaciclib plus an aromatase inhibitor as initial therapy in women with HR+, HER2- advanced breast cancer. Cancer Research. 79(4_Supplement). P6–16. 2 indexed citations

Colomban, Olivier, Margaret C. Tod, I. L. Ray-Coquard, et al.. (2016). The predictive value of the CA-125 modeled kinetic parameter KELIM is validated in 3 independent datasets (AGO-OVAR 7 & 9; ICON 7 AGO/GINECO/GCIG trials). Annals of Oncology. 27. vi296–vi296.

Banyś, Małgorzata, Erich‐Franz Solomayer, Gerhard Gebauer, et al.. (2013). Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 10(2). 2 indexed citations

Huober, J., Patrik Weder, Epie Boven, et al.. (2013). Abstract OT1-1-05: Pernetta: A randomized phase II trial of pertuzumab + trastuzumab with or without chemotherapy, both followed by T-DM1 at progression, in patients with HER2-positive metastatic breast cancer - SAKK 22/10 / UNICANCER UC-0140/1207. Cancer Research. 73(24_Supplement). OT1–1.

Banyś, Małgorzata, Gerhard Gebauer, Natalia Krawczyk, et al.. (2012). Bisphosphonates may improve survival of breast cancer patients with disseminated tumor cells in bone marrow. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 9(2). 1 indexed citations

10.

Huober, J., Jian Wu, Anita Giobbie‐Hurder, et al.. (2011). Symptoms of endocrine treatment and outcome: A retrospective analysis of the monotherapy arms of the BIG 1-98 trial.. Journal of Clinical Oncology. 29(15_suppl). 522–522. 6 indexed citations

11.

Möbus, Volker, Nadia Harbeck, Dirk Elling, et al.. (2011). S2-4: GAIN Study: A Phase III Trial To Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients with Node-Positive Primary Breast Cancer – 1st Interim Efficacy Analysis.. Cancer Research. 71(24_Supplement). S2–4. 18 indexed citations

12.

Minckwitz, G von, M. Kaufmann, Sherko Kümmel, et al.. (2011). PD07-05: Local Recurrence Risk in 6377 Patients with Early Breast Cancer Receiving Neoadjuvant Anthracycline-Taxane +/− Trastuzumab Containing Chemotherapy.. Cancer Research. 71(24_Supplement). PD07–5. 1 indexed citations

13.

Minckwitz, Gϋnter von, Bettina Conrad, Carsten Denkert, et al.. (2009). 0148 REACT study: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patients. The Breast. 18. S56–S56. 1 indexed citations

14.

Minckwitz, G von, Sherko Kümmel, Claus Hanusch, et al.. (2008). Neoadjuvant Vinorelbine-Capecitabine Versus Docetaxel-Doxorubicin-Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial. JNCI Journal of the National Cancer Institute. 100(8). 542–551. 210 indexed citations

15.

Krauss, Katja, Cornelia Bachmann, Jakob Hartmann, et al.. (2007). Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole.. PubMed. 27(5B). 3477–80. 21 indexed citations

16.

Harter, Philipp, J. Huober, Jacobus Pfisterer, et al.. (2007). A phase I dose escalation and pharmacokinetic study of BIBF 1120 in combination with paclitaxel and carboplatin in patients with advanced gynecological malignancies. Journal of Clinical Oncology. 25(18_suppl). 3561–3561. 8 indexed citations

17.

Kraemer, Bernhard, Charles A. Mack, J. Huober, et al.. (2005). Bone mass in patients with primary breast cancer: Measurements of the calcaneus by ultrasonometry. Journal of Clinical Oncology. 23(16_suppl). 827–827. 2 indexed citations

18.

Seeger, Harald, J. Huober, D. Wallwiener, & A. O. Mueck. (2004). Inhibition of Human Breast Cancer Cell Proliferation with Estradiol Metabolites is as Effective as with Tamoxifen. Hormone and Metabolic Research. 36(5). 277–280. 31 indexed citations

19.

Mueck, A. O., Harald Seeger, D. Wallwiener, & J. Huober. (2004). Is the combination with 2-methoxyestradiol able to reduce the dosages of chemotherapeutices in the treatment of human ovarian cancer? Preliminary in vitro investigations.. PubMed. 25(6). 699–701. 10 indexed citations

20.

Hamann, Ute, Serban Dan Costa, Karl Götte, et al.. (1997). Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters. The Breast. 6(1). 1–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact